AroCell AB Valuation
| AROC Stock | SEK 0.57 0.02 3.39% |
AroCell AB is overvalued. AroCell AB shows a prevailing Real Value of kr0.45 per share. The current price of the firm is kr0.57. Our model approximates the value of AroCell AB from analyzing the firm fundamentals such as Profit Margin of (2.04) %, return on equity of -0.26, and Current Valuation of 63.02 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that AroCell AB's price fluctuation is out of control at this time. Calculation of the real value of AroCell AB is based on 3 months time horizon. Increasing AroCell AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
AroCell AB's intrinsic value may or may not be the same as its current market price of 0.57, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.57 | Real 0.45 | Hype 0.57 | Naive 0.63 |
The intrinsic value of AroCell AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence AroCell AB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of AroCell AB helps investors to forecast how AroCell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AroCell AB more accurately as focusing exclusively on AroCell AB's fundamentals will not take into account other important factors: AroCell AB Total Value Analysis
AroCell AB is presently anticipated to have takeover price of 63.02 M with market capitalization of 152.77 M, debt of 0, and cash on hands of 21.43 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AroCell AB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
63.02 M | 152.77 M | 0 | 21.43 M |
AroCell AB Investor Information
About 42.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.55. Some equities with similar Price to Book (P/B) outperform the market in the long run. AroCell AB recorded a loss per share of 0.5. The entity had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from AroCell AB's historical financial statements, AroCell AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.AroCell AB Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AroCell AB has an asset utilization ratio of 5.27 percent. This implies that the Company is making kr0.0527 for each dollar of assets. An increasing asset utilization means that AroCell AB is more efficient with each dollar of assets it utilizes for everyday operations.AroCell AB Ownership Allocation
AroCell AB holds a total of 230.36 Million outstanding shares. AroCell AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.AroCell AB Profitability Analysis
The company reported the revenue of 12 M. Net Loss for the year was (50.02 M) with loss before overhead, payroll, taxes, and interest of (5.04 M).About AroCell AB Valuation
The stock valuation mechanism determines AroCell AB's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of AroCell AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of AroCell AB. We calculate exposure to AroCell AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AroCell AB's related companies.AroCell AB , a vitro diagnostics company, focuses on the monitoring of hematological malignancies, breast cancer, and other solid tumors. AroCell AB was founded in 2003 and is based in Uppsala, Sweden. AroCell AB is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct AroCell AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AroCell AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AroCell AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AroCell AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AroCell AB's revenue streams: Identify AroCell AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AroCell AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AroCell AB's growth potential: Evaluate AroCell AB's management, business model, and growth potential.
- Determine AroCell AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AroCell AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for AroCell Stock Analysis
When running AroCell AB's price analysis, check to measure AroCell AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AroCell AB is operating at the current time. Most of AroCell AB's value examination focuses on studying past and present price action to predict the probability of AroCell AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AroCell AB's price. Additionally, you may evaluate how the addition of AroCell AB to your portfolios can decrease your overall portfolio volatility.